Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344666 · ClinicalTrials.gov registry record · NA
SafERteens M-Coach
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03344666: Completed NA study, sponsored by University of Michigan.
NCT03344666 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03344666, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
This study will use a SMART (Sequential, Multiple Assignment Randomized Trial) design to optimize adaptive interventions (AIs) for adolescents reporting alcohol misuse and violent behaviors. The study will test the efficacy of state-of-the-art adaptive intervention delivery approaches (text messaging, remote therapy) for reducing alcohol use and violent behaviors among urban teens. Given the morbidly/mortality associated with alcohol use and violence, this study will have significant impact by using a SMART design to identify the optimal intervention strategy to produce and sustain outcomes among at-risk youth.
Primary Outcome
Alcohol consumption will be assessed using the 30-day Timeline Follow-Back (TLFB). The TLFB will capture information on the frequency and quantity of alcohol use including binge drinking, with total consumption calculated.
Interventions
- BEHAVIORAL Step 1 Treatment BI+HC
- BEHAVIORAL Step 1 Treatment BI+TM
- BEHAVIORAL Step 2 Treatment Responders
- BEHAVIORAL Step 2 Treatment Non-Responders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-07-25 |
| Phase | NA |
What the finished NCT03344666 record still lists
NCT03344666 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 4 interventions - of which Step 1 Treatment BI+HC is the first listed.
NCT03344666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03344666 about?
NCT03344666 is a clinical study titled "SafERteens M-Coach". This study will use a SMART (Sequential, Multiple Assignment Randomized Trial) design to optimize adaptive interventions (AIs) for adolescents reporting alcohol misuse and violent behaviors. The study will test the efficacy of state-of-the-art adaptive intervention delivery approaches (text messagin...
What is the current status of trial NCT03344666?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-05-01. Estimated completion is 2023-07-25.
What interventions are being tested in trial NCT03344666?
The interventions under investigation include: Step 1 Treatment BI+HC (BEHAVIORAL), Step 1 Treatment BI+TM (BEHAVIORAL), Step 2 Treatment Responders (BEHAVIORAL), Step 2 Treatment Non-Responders (BEHAVIORAL).
Who is sponsoring clinical trial NCT03344666?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03344666's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI